A new study details how a nasal spray formulated by investigators from Brigham and Women's Hospital may work to protect ...

A new preclinical model using CRISPR, an advanced technology that allows scientists to cut and edit genes, has given Weill Cornell Medicine researchers and their colleagues a deeper insight into ...

Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the ...

Hudson Therapeutics, a leading innovator in therapeutic solutions and a US subsidiary of Shaperon, announced Shaperon’s entry ...

In preclinical studies, a team of researchers from Mount Sinai Health System in New York City and City of Hope in Los Angeles have made significant strides in diabetes treatment. They discovered a ...

A new preclinical model using CRISPR, an advanced technology that allows scientists to cut and edit genes, has given researchers a deeper insight into how prostate cancer spreads or metastasizes.

PharmaLegacy Laboratories, a provider of in vitro and in vivo preclinical drug development services, has acquired BTS ...

The Orphan Drug designation is supported by positive preclinical data from bleomycin-induced mouse models and patient-derived skin fibroblasts.

A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the ...

Oral Presentation Details: Title: ZW220, a NaPi2b-directed topoisomerase I inhibitor Antibody-Drug Conjugate, demonstrates compelling preclinical activity in NSCLC, ovarian and uterine cancer ...

Since this month of September, the Department of Medicine and Life Sciences (MELIS) at Pompeu Fabra University is ...